Virtus LifeSci Biotech Products ETF
19 hedge funds and large institutions have $8.58M invested in Virtus LifeSci Biotech Products ETF in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
7
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$695K |
| 2 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
+$297K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$210K |
| 4 |
SMG
Smart Money Group
Eastland,
Texas
|
+$165K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$68.2K |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$860K |
| 2 |
Morgan Stanley
New York
|
-$300K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$54.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21.4K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$20K |
